As there is no meaningful expression of GLP-1 receptors on hepatocytes, the major effect of GLP-1 agonists on MASH is likely to be indirect and may be related to a reduction in calorie intake, body weight and insulin resistance, all of which would lead to reduced liver lipid accumulation and hepatic inflammation 7,8
Setmelanotide is a selective MC4R agonist that reached regulatory approval for specific rare genetic obesity indications, and it is the appropriate comparator if MC4R is your question
Baekdal TA, Breitschaft A, Navarria A, Hansen CW
The participants who used semaglutide also saw greater improvements in their cardiometabolic health compared to those who only received the placebo
Am J Cardiol 99:27B40B Sertznig P, Seifert M, Tilgen W, Reichrath J (2008) Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases